Alexandre Müller
Investor Relations Contact bei MEYER BURGER TECHNOLOGY AG
Profil
Alexandre Müller currently works at Kardex Holding AG, as Head-Investor Relations & Media Contact, Meyer Burger Technology AG, as Investor Relations Contact, and Dynamics Group AG, as Partner from 2008.
Mr. Müller also formerly worked at Bellevue Asset Management AG, as Portfolio Manager and Novo Nordisk Pharma AG, as Product Manager.
Mr. Müller received his graduate degree from Swiss Federal Institute of Technology.
Aktive Positionen von Alexandre Müller
Unternehmen | Position | Beginn |
---|---|---|
MEYER BURGER TECHNOLOGY AG | Investor Relations Contact | - |
KARDEX HOLDING AG | Investor Relations Contact | - |
Dynamics Group AG
Dynamics Group AG Investment ManagersFinance Dynamics Group AG is an independent Swiss investment research firm which was founded by Franz Egle in 2006. Headquartered in Zurich, the firm offers comprehensive consulting services with a focus on?Corporate Communications, Capital Market Communication, Public Affairs as well as Reputation Management and Crisis Communication. Research and Analysis is supported by a team of 30 financial analysts and market researchers in India. | Analyst-Equity | 26.02.2008 |
Ehemalige bekannte Positionen von Alexandre Müller
Unternehmen | Position | Ende |
---|---|---|
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Portfolio Manager-Equities | - |
Ausbildung von Alexandre Müller
Swiss Federal Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
KARDEX HOLDING AG | Electronic Technology |
MEYER BURGER TECHNOLOGY AG | Electronic Technology |
Private Unternehmen | 3 |
---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
Dynamics Group AG
Dynamics Group AG Investment ManagersFinance Dynamics Group AG is an independent Swiss investment research firm which was founded by Franz Egle in 2006. Headquartered in Zurich, the firm offers comprehensive consulting services with a focus on?Corporate Communications, Capital Market Communication, Public Affairs as well as Reputation Management and Crisis Communication. Research and Analysis is supported by a team of 30 financial analysts and market researchers in India. | Finance |
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |